Top Buy
| Security | Buy | Sell ▲ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Amicus Therapeutics Inc. | 8 | 0 | 1 | 0 | €10.30 | €17.63 | 71.213% |
| Jazz Pharmaceuticals plc | 30 | 0 | 1 | 0 | €96.98 | €183.41 | 89.126% |
| Icon plc | 24 | 0 | 0 | 0 | €282.90 | €324.79 | 14.807% |
| Horizon Pharma plc | 2 | 0 | 0 | 0 | €110.40 | - | - |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | €108.00 | €150.00 | 38.889% |
| Perrigo Co. plc | 4 | 0 | 0 | 0 | €25.38 | €35.01 | 37.925% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €67.40 | €65.00 | -3.561% |
| QIAGEN NV | 12 | 0 | 0 | 0 | €40.47 | €47.52 | 17.415% |
| Repligen Corp. | 15 | 0 | 0 | 0 | €130.80 | €178.01 | 36.095% |
| Medpace Holdings Inc | 16 | 0 | 0 | 0 | €310.80 | €416.61 | 34.044% |
| Hutchison China MediTech Ltd ADR | 3 | 0 | 0 | 0 | €16.00 | €20.23 | 26.439% |
| Neurocrine Bioscience | 44 | 0 | 4 | 0 | €106.75 | €149.47 | 40.021% |
| Exelixis Inc. | 21 | 0 | 2 | 0 | €23.05 | €26.01 | 12.826% |
| Novocure Ltd | 1 | 0 | 0 | 0 | €15.08 | - | - |
| Halozyme Therapeutics Inc. | 22 | 0 | 4 | 0 | €54.62 | €56.47 | 3.385% |
| Evotec SE | 10 | 1 | 8 | 0 | €6.10 | €7.00 | 14.848% |
| Nektar Therapeutics | 4 | 1 | 0 | 0 | €1.00 | €2.40 | 141.206% |
| Acadia Pharmaceuticals | 35 | 1 | 6 | 0 | €14.62 | €29.92 | 104.620% |
| United Therapeutics | 27 | 1 | 3 | 0 | €315.10 | €315.21 | 0.035% |
| Alnylam Pharmace. | 48 | 1 | 5 | 1 | €226.60 | €270.99 | 19.590% |
| Agios Pharmaceuticals Inc. | 9 | 1 | 0 | 0 | €40.60 | €48.75 | 20.072% |
| Ultragenyx Pharmaceutical Inc. | 25 | 1 | 1 | 0 | €50.50 | €84.74 | 67.810% |
| Arrowhead Pharmaceuticals Inc. | 20 | 2 | 3 | 0 | €20.95 | €54.98 | 162.439% |